首页 > 最新文献

Casopis lekaru ceskych最新文献

英文 中文
Optimizing nutrition for the treatment of lipedema: new pathways to improved quality of life. 优化营养治疗脂肪性水肿:提高生活质量的新途径。
Q4 Medicine Pub Date : 2023-01-01
Monika Kunzová

Lipedema, a chronic disease characterized by excessive fatty tissue deposition in the hips, buttocks, and lower legs, significantly negatively impacts the quality of life of those affected. This disease, which almost exclusively affects women, is often underdiagnosed, and confused with obesity. Diagnosis of lipedema is crucial for initial treatment and improvement of the patient's quality of life. Hormonal changes, inflammation, and tissue fibrosis play an essential role in the pathogenesis of lipedema. This article presents nutritional strategies that may bring relief to patients with lipedema. Nutritional intervention for lipedema patients could be an adjunct to traditional treatment, improving quality of life and reducing pain. However, these findings must be subjected to further research and clinical trials. The exact mechanism by which diet affects lipedema remains incompletely understood and, therefore, requires further study. However, this work provides hope and direction for future therapeutic approaches and research in treating lipedema.

脂肪性水肿是一种以臀部、臀部和小腿脂肪组织过度沉积为特征的慢性疾病,严重影响患者的生活质量。这种几乎只影响女性的疾病往往诊断不足,并与肥胖症混淆。脂肪性水肿的诊断对于初期治疗和改善患者的生活质量至关重要。荷尔蒙变化、炎症和组织纤维化在脂肪性水肿的发病机制中起着至关重要的作用。本文介绍了可缓解脂肪性水肿患者病情的营养策略。对脂肪性水肿患者进行营养干预可作为传统治疗的辅助手段,改善生活质量并减轻疼痛。然而,这些研究结果还必须经过进一步的研究和临床试验。饮食影响脂肪性水肿的确切机制仍未完全清楚,因此还需要进一步研究。不过,这项工作为未来治疗脂肪性水肿的治疗方法和研究提供了希望和方向。
{"title":"Optimizing nutrition for the treatment of lipedema: new pathways to improved quality of life.","authors":"Monika Kunzová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lipedema, a chronic disease characterized by excessive fatty tissue deposition in the hips, buttocks, and lower legs, significantly negatively impacts the quality of life of those affected. This disease, which almost exclusively affects women, is often underdiagnosed, and confused with obesity. Diagnosis of lipedema is crucial for initial treatment and improvement of the patient's quality of life. Hormonal changes, inflammation, and tissue fibrosis play an essential role in the pathogenesis of lipedema. This article presents nutritional strategies that may bring relief to patients with lipedema. Nutritional intervention for lipedema patients could be an adjunct to traditional treatment, improving quality of life and reducing pain. However, these findings must be subjected to further research and clinical trials. The exact mechanism by which diet affects lipedema remains incompletely understood and, therefore, requires further study. However, this work provides hope and direction for future therapeutic approaches and research in treating lipedema.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 6","pages":"248-250"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The way to data: opinions and recommendations for the provision of health data for secondary use. 获取数据的途径:关于提供供二次使用的卫生数据的意见和建议。
Q4 Medicine Pub Date : 2023-01-01
Aleš Tichopád, Martin Augustynek, Jiří Beneš, Martin Dlouhý, Tomáš Doležal, Dana Horáková, Michal Kršek, Lenka Lhotska, Petr Panzner, Marek Penhaker, Miroslav Petr, Jan Piťha, Boris Popesko, Martin Rožánek, Miloš Táborský, Michal Vrablík

Healthcare data held by state-run organisations is a valuable intangible asset for society. Its use should be a priority for its administrators and the state. A completely paternalistic approach by administrators and the state is undesirable, however much it aims to protect the privacy rights of persons registered in databases. In line with European policies and the global trend, these measures should not outweigh the social benefit that arises from the analysis of these data if the technical possibilities exist to sufficiently protect the privacy rights of individuals. Czech society is having an intense discussion on the topic, but according to the authors, it is insufficiently based on facts and lacks clearly articulated opinions of the expert public. The aim of this article is to fill these gaps. Data anonymization techniques provide a solution to protect individuals' privacy rights while preserving the scientific value of the data. The risk of identifying individuals in anonymised data sets is scalable and can be minimised depending on the type and content of the data and its use by the specific applicant. Finding the optimal form and scope of deidentified data requires competence and knowledge on the part of both the applicant and the administrator. It is in the interest of the applicant, the administrator, as well as the protected persons in the databases that both parties show willingness and have the ability and expertise to communicate during the application and its processing.

国有组织持有的医疗保健数据是社会宝贵的无形资产。它的使用应该是管理者和州政府的首要任务。管理者和政府完全家长式的做法是不可取的,无论它多么旨在保护在数据库中注册的个人的隐私权。根据欧洲政策和全球趋势,如果存在足够保护个人隐私权的技术可能性,这些措施不应超过对这些数据进行分析所产生的社会效益。捷克社会正在对这个话题进行激烈的讨论,但据作者说,它缺乏充分的事实依据,也缺乏明确的专家公众意见。本文的目的就是填补这些空白。数据匿名化技术提供了一种既保护个人隐私权又保留数据科学价值的解决方案。在匿名数据集中识别个人的风险是可扩展的,可以根据数据的类型和内容以及特定申请人的使用情况将其降至最低。找到去标识数据的最佳形式和范围需要申请人和管理员双方的能力和知识。在申请及其处理过程中,双方表现出意愿、能力和专业知识进行沟通,符合申请人、管理员以及数据库中受保护人员的利益。
{"title":"The way to data: opinions and recommendations for the provision of health data for secondary use.","authors":"Aleš Tichopád,&nbsp;Martin Augustynek,&nbsp;Jiří Beneš,&nbsp;Martin Dlouhý,&nbsp;Tomáš Doležal,&nbsp;Dana Horáková,&nbsp;Michal Kršek,&nbsp;Lenka Lhotska,&nbsp;Petr Panzner,&nbsp;Marek Penhaker,&nbsp;Miroslav Petr,&nbsp;Jan Piťha,&nbsp;Boris Popesko,&nbsp;Martin Rožánek,&nbsp;Miloš Táborský,&nbsp;Michal Vrablík","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Healthcare data held by state-run organisations is a valuable intangible asset for society. Its use should be a priority for its administrators and the state. A completely paternalistic approach by administrators and the state is undesirable, however much it aims to protect the privacy rights of persons registered in databases. In line with European policies and the global trend, these measures should not outweigh the social benefit that arises from the analysis of these data if the technical possibilities exist to sufficiently protect the privacy rights of individuals. Czech society is having an intense discussion on the topic, but according to the authors, it is insufficiently based on facts and lacks clearly articulated opinions of the expert public. The aim of this article is to fill these gaps. Data anonymization techniques provide a solution to protect individuals' privacy rights while preserving the scientific value of the data. The risk of identifying individuals in anonymised data sets is scalable and can be minimised depending on the type and content of the data and its use by the specific applicant. Finding the optimal form and scope of deidentified data requires competence and knowledge on the part of both the applicant and the administrator. It is in the interest of the applicant, the administrator, as well as the protected persons in the databases that both parties show willingness and have the ability and expertise to communicate during the application and its processing.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 2-3","pages":"61-66"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9856931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatocellular carcinoma, multiple primary neoplasia, and their association with diabetes type 2. 肝细胞癌、多发性原发瘤变及其与2型糖尿病的关系
Q4 Medicine Pub Date : 2023-01-01
Lucie Žabová, Petr Hříbek, Johana Klasová, Kateřina Příhodová, Petr Urbánek

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a frequent fatal complication of chronic liver diseases in the stage of liver cirrhosis. HCC develops at a higher rate in patients with type 2 diabetes mellitus (DM2). DM2 is associated with an increased risk of developing malignant tumors. The term multiple primary neoplasia (MPN) is used to describe the occurrence of multiple primary tumors of different organs in the same individual. To the best of the authors knowledge, the topic of the association between HCC and MPN and DM2 has not been addressed in the Czech literature. Here we present the outcomes of retrospective statistical analysis of a cohort of patients with HCC who were dispensed at the Internal Medicine Clinic of the 1st Faculty of Medicine of the Charles University in the period 2011-2021 and the impact of DM2 and MPN on overall survival (OS). MPNs are relatively common in patients with HCC. The occurrence of MPNs in our cohort was associated with DM2 in half of the cases. Median OS in HCC patients was not significantly affected by the coincidence of DM2 and/or MPNs.

肝细胞癌(HCC)是最常见的原发性肝癌,也是肝硬化期慢性肝病常见的致死性并发症。2型糖尿病(DM2)患者发生HCC的几率更高。DM2与患恶性肿瘤的风险增加有关。多发性原发瘤(multiple primary neoplasia, MPN)一词用于描述同一个体在不同器官发生的多发性原发肿瘤。据作者所知,在捷克文献中尚未涉及HCC与MPN和DM2之间关系的主题。在这里,我们介绍了2011-2021年期间在查尔斯大学第一医学院内科诊所就诊的HCC患者队列的回顾性统计分析结果以及DM2和MPN对总生存期(OS)的影响。mpn在HCC患者中相对常见。在我们的队列中,半数病例的mpn与DM2相关。HCC患者的中位OS不受DM2和/或mpn的巧合的显著影响。
{"title":"Hepatocellular carcinoma, multiple primary neoplasia, and their association with diabetes type 2.","authors":"Lucie Žabová,&nbsp;Petr Hříbek,&nbsp;Johana Klasová,&nbsp;Kateřina Příhodová,&nbsp;Petr Urbánek","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a frequent fatal complication of chronic liver diseases in the stage of liver cirrhosis. HCC develops at a higher rate in patients with type 2 diabetes mellitus (DM2). DM2 is associated with an increased risk of developing malignant tumors. The term multiple primary neoplasia (MPN) is used to describe the occurrence of multiple primary tumors of different organs in the same individual. To the best of the authors knowledge, the topic of the association between HCC and MPN and DM2 has not been addressed in the Czech literature. Here we present the outcomes of retrospective statistical analysis of a cohort of patients with HCC who were dispensed at the Internal Medicine Clinic of the 1st Faculty of Medicine of the Charles University in the period 2011-2021 and the impact of DM2 and MPN on overall survival (OS). MPNs are relatively common in patients with HCC. The occurrence of MPNs in our cohort was associated with DM2 in half of the cases. Median OS in HCC patients was not significantly affected by the coincidence of DM2 and/or MPNs.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 2-3","pages":"112-118"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9856933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical drainage, the origins and where we are today. 外科引流,起源和我们今天的处境。
Q4 Medicine Pub Date : 2023-01-01
Ján Hrubovčák, Ubomír Tulinský, Ivana Slívová, Petr Jelínek, František Jalůvka, Petr Ostruszka, Ubor Bialy

The use of drains in surgery has a rich history. Since ancient times, drainage has experienced a long progress, and its development has continued all the way to the present era. Both the indications for drainage and the material of surgical drains have changed over the last 2500 years. Indeed, drainage as we know today, was not always a practice so common or generally so well accepted, as it is today. The current concept of surgical drainage has witnessed not only periods of success, but also dead ends and mistakes of both science and medicine.

引流管在外科手术中的应用有着丰富的历史。自古以来,排水事业经历了漫长的发展,其发展一直延续到今天。在过去的2500年里,引流的适应症和手术引流的材料都发生了变化。事实上,正如我们今天所知,排水并不总是像今天这样普遍或普遍接受的做法。目前的外科引流概念不仅有成功的时期,也有科学和医学的死胡同和错误。
{"title":"Surgical drainage, the origins and where we are today.","authors":"Ján Hrubovčák,&nbsp;Ubomír Tulinský,&nbsp;Ivana Slívová,&nbsp;Petr Jelínek,&nbsp;František Jalůvka,&nbsp;Petr Ostruszka,&nbsp;Ubor Bialy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The use of drains in surgery has a rich history. Since ancient times, drainage has experienced a long progress, and its development has continued all the way to the present era. Both the indications for drainage and the material of surgical drains have changed over the last 2500 years. Indeed, drainage as we know today, was not always a practice so common or generally so well accepted, as it is today. The current concept of surgical drainage has witnessed not only periods of success, but also dead ends and mistakes of both science and medicine.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 2-3","pages":"119-121"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9900165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vlastimil Dostálek, MD - the founder of the ENT department in Nový Jičín - and his followers. Vlastimil Dostálek,医学博士,NovýJičín耳鼻喉科的创始人,以及他的追随者。
Q4 Medicine Pub Date : 2023-01-01
Ivan Kalivoda, Pavel Večeřa

Vlastimil Dostálek was born on January 18th, 1910, in the village of Včelary. Within his university studies in Brno, he was interested in otorhinolaryngology and subsequent the graduating from the medical faculty of Masaryk University, dr. Dostálek began to devote himself entirely to this field. He worked in various ENT departments led by important protagonists of his time. After the end of the Second World War, he was entrusted with building the ENT department in Nový Jičín, which he succeeded and led this department for over three decades until 1976 when he was dismantled for political reasons. Vlastimil Dostálek contributed to the development of the field in the entire district and educated many expert doctors, making him one of the prominent personalities of the Nový Jičín region. He died in 1988 at the age of 78.

弗拉斯蒂米尔·多斯塔莱克1910年1月18日出生在Včelary村。在布尔诺的大学学习期间,Dostálek博士对耳鼻喉科感兴趣,从Masaryk大学医学院毕业后,他开始完全致力于这一领域。他在他那个时代的重要人物领导下的各个耳鼻喉科工作。第二次世界大战结束后,他被委托在NovýJičín建立耳鼻喉科,他成功地领导了这个部门30多年,直到1976年,他因政治原因被解散。Vlastimil Dostálek为整个地区该领域的发展做出了贡献,并培养了许多专业医生,使他成为NovýJičín地区的杰出人物之一。他于1988年去世,享年78岁。
{"title":"Vlastimil Dostálek, MD - the founder of the ENT department in Nový Jičín - and his followers.","authors":"Ivan Kalivoda,&nbsp;Pavel Večeřa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Vlastimil Dostálek was born on January 18th, 1910, in the village of Včelary. Within his university studies in Brno, he was interested in otorhinolaryngology and subsequent the graduating from the medical faculty of Masaryk University, dr. Dostálek began to devote himself entirely to this field. He worked in various ENT departments led by important protagonists of his time. After the end of the Second World War, he was entrusted with building the ENT department in Nový Jičín, which he succeeded and led this department for over three decades until 1976 when he was dismantled for political reasons. Vlastimil Dostálek contributed to the development of the field in the entire district and educated many expert doctors, making him one of the prominent personalities of the Nový Jičín region. He died in 1988 at the age of 78.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 4","pages":"167-171"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41116091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is abdominal pain after an injury just an injury? Case report of rare aspiration pneumonia with lung gangrene and peritoneal response in a 5-year-old child. 受伤后的腹痛只是一种伤害吗?一例5岁儿童罕见吸入性肺炎并发肺坏疽和腹膜反应的病例报告。
Q4 Medicine Pub Date : 2023-01-01
Ján Hrubovčák, Ubomír Tulinský, Peter Ihnát, Petr Jelínek, Ivana Slívová, Marcel Mitták, Jan Roman, Jan Stránský

Although pneumonia presents a relatively common diagnosis, it does not always present with classic clinical symptoms, nor does it follow a regular course without complications. The presented case describes a rare case of aspiration necrotizing pneumonia, which despite intensive therapy, progressed to lung gangrene and required a lung lobectomy. Another peculiarity is that the correct diagnosis was established only after the onset of abdominal pain, surprisingly by a trauma surgeon. This case emphasizes the necessity of a thorough general examination and draws attention to a rare, but conservatively intractable necrotizing pneumonia complicated by lung gangrene.

尽管肺炎是一种相对常见的诊断,但它并不总是表现出典型的临床症状,也不遵循常规病程而没有并发症。该病例描述了一例罕见的吸入性坏死性肺炎,尽管进行了强化治疗,但仍发展为肺坏疽,需要进行肺叶切除术。另一个特点是,正确的诊断是在腹痛发作后才确定的,令人惊讶的是,创伤外科医生。该病例强调了彻底全身检查的必要性,并提请注意一种罕见但保守的顽固性坏死性肺炎并发肺坏疽。
{"title":"Is abdominal pain after an injury just an injury? Case report of rare aspiration pneumonia with lung gangrene and peritoneal response in a 5-year-old child.","authors":"Ján Hrubovčák,&nbsp;Ubomír Tulinský,&nbsp;Peter Ihnát,&nbsp;Petr Jelínek,&nbsp;Ivana Slívová,&nbsp;Marcel Mitták,&nbsp;Jan Roman,&nbsp;Jan Stránský","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although pneumonia presents a relatively common diagnosis, it does not always present with classic clinical symptoms, nor does it follow a regular course without complications. The presented case describes a rare case of aspiration necrotizing pneumonia, which despite intensive therapy, progressed to lung gangrene and required a lung lobectomy. Another peculiarity is that the correct diagnosis was established only after the onset of abdominal pain, surprisingly by a trauma surgeon. This case emphasizes the necessity of a thorough general examination and draws attention to a rare, but conservatively intractable necrotizing pneumonia complicated by lung gangrene.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 4","pages":"160-163"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41098051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective. 白细胞介素6在Castleman病发病机制和治疗中的作用——免疫学家的观点。
Q4 Medicine Pub Date : 2023-01-01
Tomáš Milota, Zuzana Střížová, Marta Sobotková, Jiřina Bartůňková

Castleman disease (CD) is a heterogeneous group of diseases characterized by lymphadenopathy and systemic inflammatory manifestations. CD can be divided into uni- (UCD) and multicentric form (MCD) according to the disease extent. MCD is usually accompanied by the features of a systemic inflammatory response including fever, weight loss, hepatosplenomegaly, ascites, and edema. In these patients, we can also observe elevation of inflammatory parameters and anemia within the laboratory assessment. Based on etiological nature, the CD can be further divided into human herpesvirus-8-associated (HHV8-associated) and idiopathic form. Interleukin 6 (IL-6) plays a central role in the disease pathogenesis. Inhibition of IL-6 has been shown to be an effective treatment modality. Currently, siltuximab, a chimeric monoclonal antibody targeting IL-6, is the only approved treatment for MCD. Its short-term and long-term efficacy and safety have been demonstrated in a few clinical studies.

Castleman病(CD)是一种异质性疾病,以淋巴结病变和全身炎症表现为特征。CD按病变程度可分为单中心型(UCD)和多中心型(MCD)。MCD通常伴有全身性炎症反应,包括发烧、体重减轻、肝脾肿大、腹水和水肿。在这些患者中,我们还可以在实验室评估中观察到炎症参数升高和贫血。根据病因性质,CD可进一步分为人类疱疹病毒-8相关(hhv8相关)和特发性形式。白细胞介素6 (IL-6)在疾病的发病机制中起核心作用。抑制IL-6已被证明是一种有效的治疗方式。目前,靶向IL-6的嵌合单克隆抗体siltuximab是唯一被批准的MCD治疗药物。其短期和长期的有效性和安全性已在一些临床研究中得到证实。
{"title":"The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective.","authors":"Tomáš Milota,&nbsp;Zuzana Střížová,&nbsp;Marta Sobotková,&nbsp;Jiřina Bartůňková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Castleman disease (CD) is a heterogeneous group of diseases characterized by lymphadenopathy and systemic inflammatory manifestations. CD can be divided into uni- (UCD) and multicentric form (MCD) according to the disease extent. MCD is usually accompanied by the features of a systemic inflammatory response including fever, weight loss, hepatosplenomegaly, ascites, and edema. In these patients, we can also observe elevation of inflammatory parameters and anemia within the laboratory assessment. Based on etiological nature, the CD can be further divided into human herpesvirus-8-associated (HHV8-associated) and idiopathic form. Interleukin 6 (IL-6) plays a central role in the disease pathogenesis. Inhibition of IL-6 has been shown to be an effective treatment modality. Currently, siltuximab, a chimeric monoclonal antibody targeting IL-6, is the only approved treatment for MCD. Its short-term and long-term efficacy and safety have been demonstrated in a few clinical studies.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 2-3","pages":"106-111"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9865007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescription rules of hormone replacement therapy and its alternative. 激素替代疗法的处方规则及其替代品。
Q4 Medicine Pub Date : 2023-01-01
Tomáš Fait

Hormone replacement therapy is still the most effective treatment for acute climacteric syndrome and prevention of osteoporosis. When starting treatment within 10 years of menopause, i.e., before the onset of irreversible changes in the vessel wall and nervous tissues, it is a window of opportunity to prevent atherosclerosis and dementia. At a later start, on the contrary, it worsens these processes. To increase the safety of the treatment, especially in affecting the breast tissue, we choose the lowest effective dose of estrogen and give preference to gestagens structurally close to progesterone. For women who, for objective or subjective reasons, prefer non-hormonal treatment, they can choose from an extensive range of complementary and alternative medicines. Unfortunately, it does not always reliable documentation of efficacy and safety from well-performed studies. However, the data for fermented soybean extract DT56a, pollen extract PI82/GC Fem, and some traditional Chinese medicine procedures offer an interesting opportunity. Physical activity cannot be forgotten in a comprehensive approach.

激素替代疗法仍然是治疗急性更年期综合征和预防骨质疏松症最有效的方法。在绝经后10年内开始治疗,即在血管壁和神经组织发生不可逆转的变化之前,这是预防动脉粥样硬化和痴呆的机会之窗。相反,在较晚的开始阶段,它会使这些过程恶化。为了增加治疗的安全性,特别是对乳腺组织的影响,我们选择最低有效剂量的雌激素,并优先使用结构上接近黄体酮的孕激素。对于出于客观或主观原因倾向于非激素治疗的妇女,她们可以从广泛的补充和替代药物中进行选择。不幸的是,它并不总是可靠的文件的有效性和安全性,从良好的研究。然而,发酵大豆提取物DT56a、花粉提取物PI82/GC Fem和一些中药程序的数据提供了一个有趣的机会。在全面的方法中不能忘记身体活动。
{"title":"Prescription rules of hormone replacement therapy and its alternative.","authors":"Tomáš Fait","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hormone replacement therapy is still the most effective treatment for acute climacteric syndrome and prevention of osteoporosis. When starting treatment within 10 years of menopause, i.e., before the onset of irreversible changes in the vessel wall and nervous tissues, it is a window of opportunity to prevent atherosclerosis and dementia. At a later start, on the contrary, it worsens these processes. To increase the safety of the treatment, especially in affecting the breast tissue, we choose the lowest effective dose of estrogen and give preference to gestagens structurally close to progesterone. For women who, for objective or subjective reasons, prefer non-hormonal treatment, they can choose from an extensive range of complementary and alternative medicines. Unfortunately, it does not always reliable documentation of efficacy and safety from well-performed studies. However, the data for fermented soybean extract DT56a, pollen extract PI82/GC Fem, and some traditional Chinese medicine procedures offer an interesting opportunity. Physical activity cannot be forgotten in a comprehensive approach.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 7-8","pages":"309-313"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9393221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assisted reproduction - principles, procedures, and their effectiveness. 辅助生殖——原则、程序及其有效性。
Q4 Medicine Pub Date : 2023-01-01
Karel Řežábek, Martina Moosová, Simona Jirsová

Assisted reproduction is an integral part of infertility treatment. The basic method is in vitro fertilisation (IVF), and intracytoplasmic sperm injection into the oocyte, cryopreservation of sperm, oocytes and embryos is also commonly used. The proportion of embryos tested with preimplantation genetic testing (PGT) for chromosomal aneuploidy or defects in specific genes is increasing. The use of donated oocytes is also significant, particularly because of the depletion of ovarian reserve in women over 40 years of age. The effectiveness of treatment is always very fundamentally dependent on the age of the woman. Assisted reproductive treatment is very well available in the Czech Republic, as is fertility preservation by sperm/oocyte freezing.

辅助生殖是不孕不育治疗的一个组成部分。基本方法是体外受精(IVF),卵母细胞内注射精子,冷冻保存精子、卵母细胞和胚胎也是常用的方法。植入前基因检测(PGT)检测染色体非整倍体或特定基因缺陷的胚胎比例正在增加。捐赠卵母细胞的使用也很重要,特别是因为40岁以上女性的卵巢储备耗尽。治疗的有效性在很大程度上取决于妇女的年龄。辅助生殖治疗在捷克共和国非常普及,通过精子/卵母细胞冷冻保存生育能力也是如此。
{"title":"Assisted reproduction - principles, procedures, and their effectiveness.","authors":"Karel Řežábek,&nbsp;Martina Moosová,&nbsp;Simona Jirsová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Assisted reproduction is an integral part of infertility treatment. The basic method is in vitro fertilisation (IVF), and intracytoplasmic sperm injection into the oocyte, cryopreservation of sperm, oocytes and embryos is also commonly used. The proportion of embryos tested with preimplantation genetic testing (PGT) for chromosomal aneuploidy or defects in specific genes is increasing. The use of donated oocytes is also significant, particularly because of the depletion of ovarian reserve in women over 40 years of age. The effectiveness of treatment is always very fundamentally dependent on the age of the woman. Assisted reproductive treatment is very well available in the Czech Republic, as is fertility preservation by sperm/oocyte freezing.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 5","pages":"179-193"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71478478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seasonal and weekly fluctuations in alcohol use in the Czech Republic. 捷克共和国酒精使用的季节性和每周波动。
Q4 Medicine Pub Date : 2023-01-01
Miroslav Barták, Jaroslav Vacek, Benjamin Petruželka, Marie Nejedlá, Vladimír Rogalewicz

Sezónní a týdenní výkyvy v užívání alkoholu patří mezi doposud neanalyzované aspekty epidemiologického výzkumu užívání alkoholu českou dospělou populací. Cílem studie je nabídnout deskriptivní a analytický pohled na sezónní a týdenní vzorce užívání alkoholu u české dospělé populace. Výzkum byl realizován na reprezentativním vzorku 809 osob v rámci on-line šetření v prostředí Českého národního panelu. Sledovanými proměnnými jsou užívání alkoholu, sezónní užívání a užívání alkoholu v rámci dní v týdnu. Výsledky ukazují, že nejčastější je konzumace v pátek, případně v sobotu, s výjimkou lidí v důchodovém věku, kteří alkohol užívání rovnoměrněji v rámci celého týdne. Z hlediska měsíců v roce je nejvyšší spotřeba uváděna v létě (červen, červenec, srpen) a v prosinci. Respondenti s vyšším skóre dotazníku AUDIT užívají alkohol více v letních měsících než v prosinci. Výsledky výzkumu mohou přispět k lepšímu časovému zacílení preventivních i klinických aktivit.

在捷克成年人口饮酒的流行病学研究中,季节性和每周饮酒波动是尚未分析的方面。这项研究的目的是对捷克成年人口的季节性和每周饮酒模式提供一个描述性和分析性的观点。这项研究是在捷克国家小组环境中对809人进行的一项在线调查的一部分。监测的变量是酒精使用、季节性使用和一周中几天内的酒精使用。结果显示,饮酒最常见于周五或周六,但退休人员除外,他们一周的饮酒量更均匀。就一年中的月份而言,夏季(6月、7月、8月)和12月的消费量最高。AUDIT得分较高的受访者在夏季饮酒量高于12月。研究结果有助于更好地安排预防和临床活动。
{"title":"Seasonal and weekly fluctuations in alcohol use in the Czech Republic.","authors":"Miroslav Barták,&nbsp;Jaroslav Vacek,&nbsp;Benjamin Petruželka,&nbsp;Marie Nejedlá,&nbsp;Vladimír Rogalewicz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Sezónní a týdenní výkyvy v užívání alkoholu patří mezi doposud neanalyzované aspekty epidemiologického výzkumu užívání alkoholu českou dospělou populací. Cílem studie je nabídnout deskriptivní a analytický pohled na sezónní a týdenní vzorce užívání alkoholu u české dospělé populace. Výzkum byl realizován na reprezentativním vzorku 809 osob v rámci on-line šetření v prostředí Českého národního panelu. Sledovanými proměnnými jsou užívání alkoholu, sezónní užívání a užívání alkoholu v rámci dní v týdnu. Výsledky ukazují, že nejčastější je konzumace v pátek, případně v sobotu, s výjimkou lidí v důchodovém věku, kteří alkohol užívání rovnoměrněji v rámci celého týdne. Z hlediska měsíců v roce je nejvyšší spotřeba uváděna v létě (červen, červenec, srpen) a v prosinci. Respondenti s vyšším skóre dotazníku AUDIT užívají alkohol více v letních měsících než v prosinci. Výsledky výzkumu mohou přispět k lepšímu časovému zacílení preventivních i klinických aktivit.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 2-3","pages":"48-51"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9900161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Casopis lekaru ceskych
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1